120 related articles for article (PubMed ID: 36596005)
1. Mortality and comorbidities in patients with bronchiectasis over a 3-year follow-up.
Mateus SP; Ribeiro-Alves M; Salles REB; Costa W; Costa CHD; Lopes AJ; Bártholo TP; Mafort TT; Tura BR; Rufino R
Medicine (Baltimore); 2022 Dec; 101(52):e32537. PubMed ID: 36596005
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis.
Zhang K; Zou X; Ma Z; Liu X; Qiu C; Xie L; Lin Z; Li S; Wu Y
Can Respir J; 2022; 2022():8175508. PubMed ID: 35308822
[TBL] [Abstract][Full Text] [Related]
3. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis.
Goeminne PC; Nawrot TS; Ruttens D; Seys S; Dupont LJ
Respir Med; 2014 Feb; 108(2):287-96. PubMed ID: 24445062
[TBL] [Abstract][Full Text] [Related]
4. Noncystic fibrosis bronchiectasis in children and adolescents: Follow-up over a decade.
Ullmann N; Porcaro F; Petreschi F; Cammerata M; Allegorico A; Negro V; Cutrera R
Pediatr Pulmonol; 2021 Sep; 56(9):3026-3034. PubMed ID: 34265867
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors in Adult Patients with Non-Cystic Fibrosis Bronchiectasis.
Machado BC; Jacques PS; Penteado LP; Roth Dalcin PT
Lung; 2018 Dec; 196(6):691-697. PubMed ID: 30255201
[TBL] [Abstract][Full Text] [Related]
6. Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis.
Diel R; Ewig S; Blaas S; Jacob C; Juelich F; Korfmann G; Sohrab S; Sutharsan S; Rademacher J
Respir Med; 2019 May; 151():121-127. PubMed ID: 31047108
[TBL] [Abstract][Full Text] [Related]
7. Effect of obstructive airway disease in patients with non-cystic fibrosis bronchiectasis.
Khalid M; Saleemi S; Zeitouni M; Al Dammas S; Khaliq MR
Ann Saudi Med; 2004; 24(4):284-7. PubMed ID: 15387496
[TBL] [Abstract][Full Text] [Related]
8. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
Paredes Aller S; Quittner AL; Salathe MA; Schmid A
Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Rehabilitation in Noncystic Fibrosis Bronchiectasis.
Ora J; Prendi E; Ritondo BL; Pata X; Spada F; Rogliani P
Respiration; 2022; 101(1):97-105. PubMed ID: 34352795
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and prognostic value of osteoporosis in hospitalized patients with bronchiectasis.
Zou X; Ma Z; Liu X; Zhang K; Qiu C; Liang R; Weng D; Xie L; Cao X; Wu Y; Wen L
BMC Pulm Med; 2023 Feb; 23(1):55. PubMed ID: 36747237
[TBL] [Abstract][Full Text] [Related]
12. Clinical, Radiological, and Microbiologic Characteristics of Patients with Noncystic Fibrosis Bronchiectasis in a Tertiary Center at Jordan.
Albtoosh AS; Altarawneh T; Toubasi AA; Malek M; Albulbol DM; Alnugaimshi SF; Altarawneh A; Alsurkhi RH; Al Oweidat K; Farah RI; Obeidat N; Salem Albtoush ES
Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389348
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease.
Martínez-García MA; de la Rosa Carrillo D; Soler-Cataluña JJ; Donat-Sanz Y; Serra PC; Lerma MA; Ballestín J; Sánchez IV; Selma Ferrer MJ; Dalfo AR; Valdecillos MB
Am J Respir Crit Care Med; 2013 Apr; 187(8):823-31. PubMed ID: 23392438
[TBL] [Abstract][Full Text] [Related]
14. Airflow limitation more than doubles the risk for hospitalization/mortality in patients with heart failure.
Bugajski A; Frazier SK; Moser DK; Chung M; Lennie TA
Eur J Cardiovasc Nurs; 2019 Mar; 18(3):245-252. PubMed ID: 30607982
[TBL] [Abstract][Full Text] [Related]
15. Does the effect of comprehensive respiratory physiotherapy home-program differ in children with cystic fibrosis and non-cystic fibrosis bronchiectasis?
Gurses HN; Ucgun H; Zeren M; Denizoglu Kulli H; Cakır E
Eur J Pediatr; 2022 Aug; 181(8):2961-2970. PubMed ID: 35595860
[TBL] [Abstract][Full Text] [Related]
16. The effect of bronchiectasis on the exacerbation and mortality of chronic obstructive pulmonary disease.
Fendoğlu TZ; Köktürk N; Yapar D; Kılıç P; Kılıç K; Erbaş G
Clin Respir J; 2021 Oct; 15(10):1113-1120. PubMed ID: 34224649
[TBL] [Abstract][Full Text] [Related]
17. The association between combined non-cystic fibrosis bronchiectasis and lung cancer in patients with chronic obstructive lung disease.
Kim YW; Jin KN; Heo EY; Park SS; Chung HS; Kim DK
Int J Chron Obstruct Pulmon Dis; 2015; 10():873-9. PubMed ID: 26005340
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary function abnormalities in adult patients with acute exacerbation of bronchiectasis: A retrospective risk factor analysis.
Ma Y; Niu Y; Tian G; Wei J; Gao Z
Chron Respir Dis; 2015 Aug; 12(3):222-9. PubMed ID: 25882894
[TBL] [Abstract][Full Text] [Related]
19. Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities.
Choi H; Yang B; Kim YJ; Sin S; Jo YS; Kim Y; Park HY; Ra SW; Oh YM; Chung SJ; Yeo Y; Park DW; Park TS; Moon JY; Kim SH; Kim TH; Yoon HJ; Sohn JW; Lee H
Sci Rep; 2021 Mar; 11(1):7126. PubMed ID: 33782457
[TBL] [Abstract][Full Text] [Related]
20. Clinical features related to hospital expenses for non-cystic fibrosis bronchiectasis in China.
Ma Y; Liu D; Ji Y; Wei X; Pan D; Xu F; Di Q; Chen X; Luo F; Zhang J; Ou G; Zhang Y; Li K; Zhang D; Wang W; Xu J; Li J; Zhu D; Tian F; Fan M
J Int Med Res; 2020 Jun; 48(6):300060520931616. PubMed ID: 32567421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
